Heartland Advisors Inc. is Buying Intricon Corp (NASDAQ:IIN) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Intricon Corp (NASDAQ:IIN) reported that Heartland Advisors Inc. has picked up 804,877 of common stock as of 2017-04-06.
The acquisition brings the aggregate amount owned by Heartland Advisors Inc. to a total of 804,877 representing a 1.8% stake in the company.
For those not familiar with the company, IntriCon Corporation is engaged in designing, developing, engineering, manufacturing and distributing body-worn devices. The Company operates through body-worn device segment. The Company serves the body-worn device market by designing, developing, engineering and manufacturing micro-miniature products, microelectronics, micro-mechanical assemblies, complete assemblies and software solutions, primarily for the value hearing health market, the medical bio-telemetry market and the professional audio communication market. The Company has facilities in Minnesota, California, Singapore, Indonesia, the United Kingdom and Germany, and operates through its subsidiaries. The Company’s product offering includes a hearing aid discount program for health plans. This program is available around the nation to health insurers, including employer-sponsored, individual and Medicare plans. The Company also has various international value hearing aid (VHA) initiatives.
A glance at Intricon Corp (NASDAQ:IIN)’s key stats reveals a current market capitalization of 55.30 Million based on 6.82 Million shares outstanding and a price at last close of $8.30 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2013-08-13, Longval picked up 1,000 at a purchase price of $3.00. This brings their total holding to 16,929 as of the date of the filing.
On the sell side, the most recent transaction saw Geraci unload 2,542 shares at a sale price of $7.58. This brings their total holding to 1,426.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Intricon Corp (NASDAQ:IIN) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Jackson Square Partners, Llc. Picked Up Tronc Inc. (NYSE:TRNC) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Tronc Inc. (NYSE:TRNC) reported that Jackson Square Partners, Llc. has picked up 7,650,000 of common stock as of 2017-04-06.
The acquisition brings the aggregate amount owned by Jackson Square Partners, Llc. to a total of 7,650,000 representing a 23.4% stake in the company.
For those not familiar with the company, tronc, Inc., formerly Tribune Publishing Company, is a media company. As of December 25, 2016, the Company operated over 150 titles in nine markets. Its portfolio of news and information brands are in markets, including Los Angeles and San Diego, California; Chicago, Illinois; Fort Lauderdale and Orlando, Florida; Baltimore, Maryland; Hartford, Connecticut; Allentown, Pennsylvania, and Newport News, Virginia. The Company also offers an array of customized marketing solutions, and publishes a number of niche products, including Hoy and El Sentinel. troncM’s media groups include the Chicago Tribune Media Group, the Los Angeles Times Media Group, the San Diego Media Group, the Sun Sentinel Media Group, the Orlando Sentinel Media Group, The Baltimore Sun Media Group, the Morning Call Media Group and the Daily Press Media Group. troncX consists of the Company’s digital revenues and related digital expenses from more than 130 digital platforms online and mobile applications.
A glance at Tronc Inc. (NYSE:TRNC)’s key stats reveals a current market capitalization of 515.00 Million based on 36.44 Million shares outstanding and a price at last close of $14.25 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2014-03-20, Soon-Shiong picked up 2,950,000 at a purchase price of $14.87. This brings their total holding to 7,650,000 as of the date of the filing.
On the sell side, the most recent transaction saw Oaktree unload 3,741,371 shares at a sale price of $15.00. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Tronc Inc. (NYSE:TRNC) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Liberty Tripadvisor Holdings Inc. (NASDAQ:LTRPA) is Attracting Smart Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Liberty Tripadvisor Holdings Inc. (NASDAQ:LTRPA) reported that Jackson Square Partners, Llc. has picked up 7,432,018 of common stock as of 2017-04-06.
The acquisition brings the aggregate amount owned by Jackson Square Partners, Llc. to a total of 7,432,018 representing a 10.31% stake in the company.
For those not familiar with the company, Liberty TripAdvisor Holdings, Inc. is a holding company. Through its interests in subsidiaries and other companies, the Company is primarily engaged in the online travel research and online commerce industries. The Company’s subsidiaries include TripAdvisor, Inc. (TripAdvisor), which owns and operates a portfolio of online travel brands, and BuySeasons, Inc., which owns and operates BuyCostumes.com and the Celebrate Express (BuySeasons) family of Websites. TripAdvisor is a travel site focusing on helping people around the world to plan and book a trip. TripAdvisor manages its business in two segments: Hotel, including click-based advertising, display-based advertising and subscription-based advertising, and Non-Hotel, including its attractions, restaurants and vacation rental businesses. BuySeasons is an online retailer and supplier of costumes, accessories, seasonal decor and party supplies.
A glance at Liberty Tripadvisor Holdings Inc. (NASDAQ:LTRPA)’s key stats reveals a current market capitalization of 1.01 Billion based on 72.07 Million shares outstanding and a price at last close of $13.40 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2014-12-22, Maffei picked up 1,845,909 at a purchase price of $27.28. This brings their total holding to 2,299,331 as of the date of the filing.
On the sell side, the most recent transaction saw Wendling unload 12 shares at a sale price of $15.51. This brings their total holding to 11,011.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Liberty Tripadvisor Holdings Inc. (NASDAQ:LTRPA) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Just Picked Up Echo Therapeutics Inc. (NASDAQ:ECTE) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Echo Therapeutics Inc. (NASDAQ:ECTE) reported that Schoenbart Alan Wayne has picked up 774,500 of common stock as of 2017-04-06.
The acquisition brings the aggregate amount owned by Schoenbart Alan Wayne to a total of 774,500 representing a 5.6% stake in the company.
For those not familiar with the company, Echo Therapeutics, Inc. is a medical device company. The Company is engaged in developing a non-invasive, wireless continuous glucose monitoring (CGM) system with use in the wearable-health consumer market, diabetes outpatient market and in the hospital setting. The Company operates through the development of transdermal skin permeation and diagnostic medical devices segment. The Company has also developed its needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, enhanced delivery of topical pharmaceuticals and other applications. The CGM System includes a skin preparation device, transdermal glucose sensor, battery and wireless transmitter. The Company has conducted several human feasibility clinical studies with its CGM System in healthy subjects, diabetics and critically ill patients, as well as a clinical study at several hospitals in the United States.
A glance at Echo Therapeutics Inc. (NASDAQ:ECTE)’s key stats reveals a current market capitalization of 1.68 Million based on 12.00 Million shares outstanding and a price at last close of $0.140 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-20-20, Schoenbart picked up 2,500 at a purchase price of $1.44. This brings their total holding to 2,500 as of the date of the filing.
On the sell side, the most recent transaction saw Young unload 10,000 shares at a sale price of $2.38. This brings their total holding to 160,874.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Echo Therapeutics Inc. (NASDAQ:ECTE) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
March Review Released for INVICTUS MD Strategies Corp (OTCMKTS:IVITF)
INVICTUS MD Strategies Corp (OTCMKTS:IVITF) shares ticked 9.75% higher to $1.27 on Wednesday and were flat in after-hours trading. Share prices have been trading in a 52-week range of $0.18 to $1.61. The company has a market cap of $43.50 million at 37.50 million shares outstanding.
INVICTUS MD Strategies Corp is a company that is focused on three main verticals within the burgeoning Canadian cannabis sector: Licensed Producers under the ACMPR including an investment in a fully licensed facility, AB Laboratories Inc. as well as the option to now acquire 100% of Acreage Pharms Ltd.; Fertilizer and Nutrients through Future Harvest Development Ltd.; and Cannabis Data and Delivery, with its wholly owned subsidiary Poda Technologies Ltd.
In a press release, INVICTUS MD Strategies Corp Chairman Dan Kriznic provided a month in review, highlighting the transformational time for the company as it worked to expand and solidify its cultivation portfolio with expansion plan forecasts of 50,000 kilograms of high quality cannabis production by 2020.
He started off by sharing that CBC News learned that marijuana could be legal in Canada by July 1, 2018 and that the legislation will be announced during the week of April 10. Analysts estimate that this industry could reach $22.6 billion over the coming years, according to Deloitte, with a retail market worth up to $8.7 billion. So far, there are only 41 producers licensed by Health Canada so there’s still significant potential for INVICTUS MD Strategies Corp to capitalize on this growth over time.
At the beginning of March, INVICTUS MD Strategies Corp announced that it had closed its previously announced bought deal private placement with Canaccord Genuity Corp. and Eventus Capital Corp., including a portion of the over-allotment option, for aggregate gross proceeds of $16,218,065. Soon after, the company completed its final commitment with a cash transaction of CAD$2,000,000 to acquire 33.33% of AB Laboratories Inc. This is a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations in Ontario.
Towards the end of the month, the company closed the definitive option agreement to acquire 100% interest in OptionCo which had received its license to cultivate under the Access to Cannabis for Medical Purposes Regulations as Acreage Pharms Ltd. It has constructed a 6,800 square foot production facility with an expansion plan floor plate of 30,000 square feet, and the option to add a 20,000 square foot mezzanine on 150 acres of land in Alberta.
As one of the few cannabis producing companies in North America listed on a major exchange such as the TSXV, that move will enable us to engage a wider investor audience,” said Dan Kriznic, Chairman & CEO, Invictus MD. “We are strongly focused on building our shareholder value. With 250 acres of cultivation space that stretches from Alberta to Ontario, allowing for purpose built production facilities rather than retrofitting existing buildings, we now have the largest land package in Canada for building cultivation facilities as demand increases and we will continue the disciplined but agile execution of our business strategy,” added Kriznic.
DISCLAIMER: There is a substantial risk of loss with any speculative asset, especially small cap stocks. The opinions expressed are those of the author, and do not constitute recommendations to buy or sell a stock. Do your own research before committing capital.
Guess Who Just Picked Up Houlihan Lokey Inc. (NYSE:HLI) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Houlihan Lokey Inc. (NYSE:HLI) reported that Hl Voting Trust has picked up 43,983,299 of common stock as of 2017-04-06.
The acquisition brings the aggregate amount owned by Hl Voting Trust to a total of 43,983,299 representing a 66.6% stake in the company.
For those not familiar with the company, Houlihan Lokey, Inc. is a global independent investment bank that focuses on mergers and acquisitions (M&A), financings, financial restructurings and financial advisory services. The Company operates through three segments: Corporate Finance, Financial Restructuring and Financial Advisory Services. The Company serves a set of clients across the world, including corporations, financial sponsors and government agencies. The Company provides financial professionals with an integrated platform that enables them to deliver advice to its clients. The Company also offers intellectual property advisory services. The Corporate Finance activities include two categories: M&A and capital markets advisory. The Financial Advisory Services segment includes financial opinions, and a range of valuation and financial consulting services in the United States. The Financial Restructuring segment provides advice to debtors and creditors in connection with recapitalization/deleveraging transactions.
A glance at Houlihan Lokey Inc. (NYSE:HLI)’s key stats reveals a current market capitalization of 2.23 Billion based on 12.83 Million shares outstanding and a price at last close of $33.95 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-02-13, Schriesheim picked up 4,870 at a purchase price of $30.73. This brings their total holding to 16,361 as of the date of the filing.
On the sell side, the most recent transaction saw Beiser unload 11,029 shares at a sale price of $29.05. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Houlihan Lokey Inc. (NYSE:HLI) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess who is Buying Vycor Medical Inc. (OTCMKTS:VYCO) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Vycor Medical Inc. (OTCMKTS:VYCO) reported that Fountainhead Capital Management Ltd has picked up 10,579,097 of common stock as of 2017-04-06.
The acquisition brings the aggregate amount owned by Fountainhead Capital Management Ltd to a total of 10,579,097 representing a 50.10% stake in the company.
For those not familiar with the company, Vycor Medical, Inc. provides surgical and therapeutic solutions. The Company operates through two segments: Vycor Medical, which focuses on brain and cervical surgical access systems for sale to hospitals and medical professionals, and NovaVision, which focuses on neuro-stimulation therapies and diagnostic devices for the treatment and screening of vision field loss resulting from neurological damage. The Company designs, develops and markets neurological medical devices and therapies. The Company operates in the United States and Europe. Vycor Medical’s product Vycor Medical’s ViewSite Brain Access System (VBAS) is a next generation retraction and access system. VBAS is a disposable product that can be used with microscopic, endoscopic and neuro-navigation systems. NovaVision has a family of therapies that both restore and compensate for lost vision. NovaVision’s products include VRT and Neuro-Eye Therapy (NeET), NeuroEyeCoach and Vision Diagnostic (VIDIT)..
A glance at Vycor Medical Inc. (OTCMKTS:VYCO)’s key stats reveals a current market capitalization of 3.48 Million based on 17.42 Million shares outstanding and a price at last close of $0.200 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2014-12-31, Fountainhead picked up 8,380 at a purchase price of $1.79. This brings their total holding to 4,366,844 as of the date of the filing.
On the sell side, the most recent transaction saw Bronsther unload 6,241 shares at a sale price of $2.75. This brings their total holding to 18,216.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Vycor Medical Inc. (OTCMKTS:VYCO) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Hughes B Wayne Et Al Picked Up American Homes 4 Rent (NYSE:AMH) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), American Homes 4 Rent (NYSE:AMH) reported that Hughes B Wayne Et Al has picked up 10,412,235 of common stock as of 2017-04-06.
The acquisition brings the aggregate amount owned by Hughes B Wayne Et Al Inc. to a total of 10,412,235 representing a 4.0% stake in the company.
For those not familiar with the company, American Homes 4 Rent is an internally managed real estate investment trust (REIT) focused on acquiring, renovating, leasing and operating single-family homes as rental properties. The Company’s primary objective is to generate attractive risk-adjusted returns for its shareholders through dividends and capital appreciation by acquiring, renovating, leasing and operating single-family homes as rental properties. As of December 31, 2016, it owned 48,422 single-family properties in 22 states, including 1,119 properties held for sale, and had an additional 47 properties in escrow that it intended to acquire. Its integrated operating platform offers property management, acquisitions, construction, marketing, leasing, financial and administrative functions. The Company may seek to invest in condominium units, townhouses and real estate-related debt investments. The Company is externally managed and advised by American Homes 4 Rent Advisor, LLC (the Advisor).
A glance at American Homes 4 Rent (NYSE:AMH)’s key stats reveals a current market capitalization of 6.08 Billion based on 257.24 Million shares outstanding and a price at last close of $23.62 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-03-22, Hughes picked up 2,192,982 at a purchase price of $22.80. This brings their total holding to 10,412,235 as of the date of the filing.
On the sell side, the most recent transaction saw Smith unload 12,000 shares at a sale price of $21.70. This brings their total holding to 20,799.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on American Homes 4 Rent (NYSE:AMH) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.